These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 20377740)

  • 1. Inhibitory effects of soluble MD-2 and soluble CD14 on bacterial growth.
    Ohnishi T; Muroi M; Tanamoto K
    Microbiol Immunol; 2010 Feb; 54(2):74-80. PubMed ID: 20377740
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stable transduction of bovine TLR4 and bovine MD-2 into LPS-nonresponsive cells and soluble CD14 promote the ability to respond to LPS.
    Sauter KS; Brcic M; Franchini M; Jungi TW
    Vet Immunol Immunopathol; 2007 Jul; 118(1-2):92-104. PubMed ID: 17559944
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recombinant bovine soluble CD14 reduces severity of experimental Escherichia coli mastitis in mice.
    Lee JW; Paape MJ; Zhao X
    Vet Res; 2003; 34(3):307-16. PubMed ID: 12791240
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Soluble CD14 and CD83 from human neonatal antigen-presenting cells are inducible by commensal bacteria and suppress allergen-induced human neonatal Th2 differentiation.
    Lundell AC; Andersson K; Josefsson E; Steinkasserer A; Rudin A
    Infect Immun; 2007 Aug; 75(8):4097-104. PubMed ID: 17526743
    [TBL] [Abstract][Full Text] [Related]  

  • 5. R-form LPS, the master key to the activation ofTLR4/MD-2-positive cells.
    Huber M; Kalis C; Keck S; Jiang Z; Georgel P; Du X; Shamel L; Sovath S; Mudd S; Beutler B; Galanos C; Freudenberg MA
    Eur J Immunol; 2006 Mar; 36(3):701-11. PubMed ID: 16506285
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Both membrane-bound and soluble forms of CD14 bind to gram-negative bacteria.
    Jack RS; Grunwald U; Stelter F; Workalemahu G; Schütt C
    Eur J Immunol; 1995 May; 25(5):1436-41. PubMed ID: 7539760
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulatory effects of sCD14 and LBP on LPS-host cell interactions.
    Kitchens RL; Thompson PA
    J Endotoxin Res; 2005; 11(4):225-9. PubMed ID: 16176659
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipopolysaccharide complexed with soluble CD14 binds to normal human monocytes.
    Blondin C; Le Dur A; Cholley B; Caroff M; Haeffner-Cavaillon N
    Eur J Immunol; 1997 Dec; 27(12):3303-9. PubMed ID: 9464818
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential effect of inhibiting MD-2 and CD14 on LPS- versus whole E. coli bacteria-induced cytokine responses in human blood.
    Christiansen D; Brekke OL; Stenvik J; Lambris JD; Espevik T; Mollnes TE
    Adv Exp Med Biol; 2012; 946():237-51. PubMed ID: 21948372
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Soluble CD14(1-152) confers responsiveness to both lipoarabinomannan and lipopolysaccharide in a novel HL-60 cell bioassay.
    Yu W; Soprana E; Cosentino G; Volta M; Lichenstein HS; Viale G; Vercelli D
    J Immunol; 1998 Oct; 161(8):4244-51. PubMed ID: 9780199
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyanobacterial LPS antagonist (CyP)-a novel and efficient inhibitor of Escherichia coli LPS-induced cytokine response in the pig.
    Thorgersen EB; Macagno A; Rossetti C; Mollnes TE
    Mol Immunol; 2008 Aug; 45(13):3553-7. PubMed ID: 18571239
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of the lipopolysaccharide receptor complex (CD14, TLR4, MD-2) and toll-like receptor 2 in systemic inflammatory response syndrome-positive patients with and without infection: relationship to tolerance.
    Calvano JE; Agnese DM; Um JY; Goshima M; Singhal R; Coyle SM; Reddell MT; Kumar A; Calvano SE; Lowry SF
    Shock; 2003 Nov; 20(5):415-9. PubMed ID: 14560104
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of Bacillus intermedius RNAases with various catalytic activity on multiplication of Escherichia coli and Bacillus subtilis].
    Kipenskaia LV; Kupriianova-Ashina FG; Il'inskaia ON; Kolpakov AI; Leshchinskaia IB
    Mikrobiologiia; 1998; 67(2):165-9. PubMed ID: 9662695
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sequence-specific bacterial growth inhibition by peptide nucleic acid targeted to the mRNA binding site of 16S rRNA.
    Hatamoto M; Nakai K; Ohashi A; Imachi H
    Appl Microbiol Biotechnol; 2009 Oct; 84(6):1161-8. PubMed ID: 19578844
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The involvement of CD14 in the activation of human monocytes by peptidoglycan monomers.
    Muhvić D; El-Samalouti V; Flad HD; Radosević-Stasić B; Rukavina D
    Mediators Inflamm; 2001 Jun; 10(3):155-62. PubMed ID: 11545252
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monocytes can phagocytose Gram-negative bacteria by a CD14-dependent mechanism.
    Grunwald U; Fan X; Jack RS; Workalemahu G; Kallies A; Stelter F; Schütt C
    J Immunol; 1996 Nov; 157(9):4119-25. PubMed ID: 8892647
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cutting edge: recognition of Gram-positive bacterial cell wall components by the innate immune system occurs via Toll-like receptor 2.
    Yoshimura A; Lien E; Ingalls RR; Tuomanen E; Dziarski R; Golenbock D
    J Immunol; 1999 Jul; 163(1):1-5. PubMed ID: 10384090
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urinary soluble CD14 mediates human proximal tubular epithelial cell injury induced by LPS.
    Bussolati B; David S; Cambi V; Tobias PS; Camussi G
    Int J Mol Med; 2002 Oct; 10(4):441-9. PubMed ID: 12239591
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The origin and function of soluble CD14 in experimental bacterial meningitis.
    Cauwels A; Frei K; Sansano S; Fearns C; Ulevitch R; Zimmerli W; Landmann R
    J Immunol; 1999 Apr; 162(8):4762-72. PubMed ID: 10202018
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The molecular basis for therapeutic concepts utilizing CD14.
    Stelter F; Bernheiden M; Menzel R; Witt S; Jack RS; Grunwald U; Fan X; Schütt C
    Prog Clin Biol Res; 1998; 397():301-13. PubMed ID: 9575571
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.